MAVELERTINIB |
MAVELERTINIB : Covalent Inhibitor of EGFR
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
More...
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| EGFR (Mutant:L858R/T790M, Del/T790M, L858R, Del) |
|
|
Covalent Inhibitor
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
An off-target assessment was performed in vitro at 10 μM against a broad panel of receptors, enzymes ...
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Analysis of PF-06747775 at 1000 nM in the Carna Biosciences Mobility Shift Assay for 274 Human Prote ...
Selectivity Assessment Description:
15 kinases of the 273 tested were inhibited >50%
In Cell Selectivity Assessment
Potency Assay Off-Target:
The identified 15 kinases were tested in follow-up enzyme assays where conditions were modified by i ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
To assess the total cellular proteome reactivity of PF-06747775, a variant was synthetized P_21 and ...
Selectivity Assessment Description:
A lack of proteome-wide reactivity was observed compared to control.
Potency Cellular
In Vitro
EGFR
(Mutant:L858R/T790M, Del/T790M, L858R, Del)
Mode of Action: Covalent Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.6b01894
In Vivo Validations
Mouse
Dose: 1 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
0.56 h
Systemic clearance:
53 mL/min/kg
Volume of Distribution at Steady-State:
1.48 L/Kg
DOI Reference: 10.1021/acs.jmedchem.6b01894
Dose: 1 mg/Kg
Route of delivery:
Oral
Bioavailability:
60%
DOI Reference: 10.1021/acs.jmedchem.6b01894
Rat
Dose: 1 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
0.28 h
Systemic clearance:
49 mL/min/kg
Volume of Distribution at Steady-State:
0.66 L/Kg
DOI Reference: 10.1021/acs.jmedchem.6b01894
Dose: 30 mg/Kg
Route of delivery:
Oral
Bioavailability:
11%
DOI Reference: 10.1021/acs.jmedchem.6b01894
Dog
Dose: 1 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
1.3 h
Systemic clearance:
12 mL/min/kg
Volume of Distribution at Steady-State:
0.94 L/Kg
DOI Reference: 10.1021/acs.jmedchem.6b01894
Dose: 3 mg/Kg
Route of delivery:
Oral
Bioavailability:
66%
DOI Reference: 10.1021/acs.jmedchem.6b01894
Chemical Information
| Molecular Formula | C18H22FN9O2 |
| SMILEs | C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(C)c3n2)C[C@H]1F |
| InChI | InChI=1S/C18H22FN9O2/c1-5-13(29)21-11-8-28(6-10(11)19)18-23-15(14-16(24-18)26(2)9-20-14)22-12-7-27(3)25-17(12)30-4/h5,7,9-11H,1,6,8H2,2-4H3,(H,21,29)(H,22,23,24)/t10-,11-/m1/s1 |
| Molecular weight | 415.19 Da |
| AlogP | 0.6778999999999995 |
| HBond acceptors | 11 |
| HBond donors | 2 |
| Atoms | 52 |